Efficacy of QBKPN Site-Specific Immunomodulator in Improving Innate Immune Function & Reducing Respiratory Tract Infection in Older Adults

NCT05421325 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Immune Deficiency

Interventions

BIOLOGICAL: QBKPN SSI
OTHER: Normal Saline Placebo

Sponsor

Qu Biologics Inc.

Collaborators

[object Object]